Giuseppina Miele

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 11, 2026

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

Journal: International journal of medical informatics

Published: January 25, 2026

Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.

Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: September 15, 2025

Clinical Efficacy of Selumetinib in Alleviating Neuropathic Pain Associated with Plexiform Neurofibroma: A Case Series.

Clinical Efficacy of Selumetinib in Alleviating Neuropathic Pain Associated with Plexiform Neurofibroma: A Case Series.

Journal: Genes

Published: May 13, 2025

Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications.

Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications.

Journal: Journal of clinical medicine

Published: April 28, 2025

Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study.

Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study.

Journal: Journal of the neurological sciences

Published: February 02, 2025

Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.

Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.

Journal: Journal of the neurological sciences

Published: December 28, 2024

Severe cervical kyphosis in a complex child with NF1, case report and literature review.

Severe cervical kyphosis in a complex child with NF1, case report and literature review.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: December 11, 2024

Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest.

Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interest.

Journal: Journal of neurology

Published: July 26, 2024

Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis.

Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis.

Journal: Journal of clinical medicine

Published: July 18, 2024

Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.

Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 25, 2024

Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.

Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.

Journal: Journal of neurology

Published: January 15, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026